Health

Undetectable viral load: further talks with Sammy

published: March, 08, 2018 Written by // Kimutai Kemboi, Categories // Activism, African, Caribbean and Black, As Prevention , Kimutai Kemboi, Treatment Guidelines -including when to start, Health, International , Treatment, Media, Opinion Pieces

From Kenya, Kimutai Kemboi on the many benefits of adherence to antiretroviral therapy (ART).

Undetectable viral load: further talks with Sammy

I must say having a talk with Sammy (as I said, not his real name) was one of the most interesting discussion I have ever had with anyone. His questions were endless, as each response gave rise to more questions but I was happy coz everything he asked was very relevant. Sammy: This is very interesting. So you mean an undetectable person can be in an intimate relationship with a negative person without posing a threat to him or her? Kemboi: (looking at my cup of tea) Just a minute Sammy, my t

New HIV infections halved after scale-up of HIV treatment, circumcision, in Uganda's hardest-hit district

published: March, 08, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Health, International , Revolving Door, Treatment, Guest Authors, Media

From AIDSmap, Michael Carter and Keith Alcorn report on the Rakai Community Cohort Study.

New HIV infections halved after scale-up of HIV treatment, circumcision, in Uganda's hardest-hit district

The rate of new HIV infections has halved since 2011 in a Ugandan community following large increases in male circumcision, antiretroviral treatment and viral suppression, Frank Kagaayi of the Rakai Health Sciences Program told the Conference on Retroviruses and Opportunistic Infections in Boston on Tuesday. Dr Kagaayi was presenting results from the Rakai Community Cohort Study, focusing on repeat surveys of one fishing village with a very high prevalence and incidence of HIV infection. The

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

published: March, 07, 2018 Written by // Guest Authors - Revolving Door Categories // International AIDS Conference , Social Media, Conferences, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Research, Health, International , Revolving Door, Treatment, Guest Authors, Media

Five of eleven treated animals still remained virally suppressed at six months. From AIDSmap, Liz Highleyman reports.

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

Dan Barouch presenting at CROI 2018. Photo by Liz Highleyman Treatment with a broadly neutralising antibody plus an immune-stimulating drug led to long-term viral remission after interrupting antiretroviral therapy in a monkey study, according to data presented at the 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) this week in Boston. Monkeys that received both the antibody, known as PGT121, and the TLR7 agonist GS-9620 maintained an undetectable viral load withou

Some Canadians spending less on food, heating because of prescription drug costs

published: March, 06, 2018 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, Current Affairs, Health, CATIE - HIV and Hep C Info Resource, Media

From CATIE, Sean R Hosein reports on a study that examines how the social determinants of health are affectIng patient adherence and outcomes.

Some Canadians spending less on food, heating because of prescription drug costs

- Researchers find 22% of prescription drug spending in Canada is out of pocket - Cost of drugs leaves many Canadians cutting back on medication and essentials - Cost-related non-adherence increases health complications and healthcare burden Canadian public health insurance plans pay for hospital and physician services that are considered medically necessary. However, prescription drugs are another matter. According to a team of researchers at universities in British Columbia and Ontario, t

Ontario expands patient access to chronic Hepatitis C therapies on public drug plan.

published: March, 06, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, Hep B and C, Current Affairs, Health, Revolving Door, Media, Guest Authors

Good news for those infected or co-infected with Hepatitis C in Ontario

Ontario expands patient access to chronic Hepatitis C therapies on public drug plan.

- Gilead applauds Ontario’s Ministry of Health for expanding access to curative hepatitis C therapies to all diagnosed patients, regardless of severity of illness - Ontario’s expanded access includes EPCLUSA®, a 12 week treatment for patients with chronic hepatitis C across all six genotypes - Gilead’s new product, VOSEVI™ is now available under the Ontario Drug Benefit Program - The removal of the fibrosis level criterion for access furthers Canada’s commitment to the World Heal

Undetectable viral load is a milestone in this journey.

published: March, 05, 2018 Written by // Kimutai Kemboi, Categories // Social Media, Activism, African, Caribbean and Black, As Prevention , Kimutai Kemboi, Treatment Guidelines -including when to start, Health, International , Treatment, Living with HIV, Media

From Kenya, Kimutai Kemboi spreads the word that undetectable equals untransmittable

Undetectable viral load is a milestone in this journey.

I had a conversation with this guy, Sammy (not his real name) and I feel I should share it so that other people learn the facts. Sammy: Hi Kim? (the short name of Kimutai) Kemboi: Hi to you bro, how is the going? Sammy: All is well, how about you? Kemboi: Everything is perfect, just up and down as a routine. Sammy: There is something that has been disturbing my mind for a while now and I have tried asking and researching but I am not convinced by the responses. That is why I thought of a

US studies underline importance of primary care physicians for people with HIV

published: March, 05, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, General Health, Health, Research, International , Revolving Door, Media, Guest Authors

From AIDSmap, Keith Alcorn reports on two studies assessing the influence of provider type on outcomes of chronic co-morbidities in HIV.

US studies underline importance of primary care physicians for people with HIV

People with HIV who have other medical conditions such as high blood pressure or high lipids appear to do better if they have a primary care physician as well as an HIV physician, according to a study of people receiving care through UCLA Center for Clinical AIDS Research and Education, researchers report in The Journal of Infectious Diseases. A second study, looking at chronic medical conditions, or co-morbidities, in a large sample of people with HIV in the United States found that high b

Chronic depression leads to poorer engagement with key stages of HIV care continuum, say US researchers

published: February, 28, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, Mental Health, Health, Research, International , Revolving Door, Media, Guest Authors

From AIDSmap, Michael Carter reports on a study designed to examine the association between chronic depression and clinical outcomes.

Chronic depression leads to poorer engagement with key stages of HIV care continuum, say US researchers

Increased time spent living with depression is associated with poorer engagement with the HIV care continuum, investigators from the United States report in JAMA Psychiatry. Chronic depression was associated with missing appointments, a detectable viral load and an increased mortality risk. “We found that a greater proportion of time spent with depression increased the risk of missed primary care appointments and lack of viral suppression in a dose-response manner,” comment the autho

HIV pre-exposure drug approved for funding in B.C., but barriers remain

published: February, 28, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Treatment Guidelines -including when to start, Health, Revolving Door, Treatment, Guest Authors, Media

From the Globe and Mail, Holly McKenzie-Sutter

HIV pre-exposure drug approved for funding in B.C., but barriers remain

ISTOCKPHOTO Oren Adamson received a prescription for pre-exposure prophylaxis treatment in July of last year. Also known as PrEP, the once daily pill is believed to reduce the risk of contracting HIV by more than 90 per cent. Health Canada approved PrEP in the form of the drug Truvada last year, but it has remained too expensive for many patients at $1,000 month. It's considerably cheaper – $70 – in the United States, prompting Mr. Adamson to drive from his home in Vancouver across the bo

Mindfulness, The Frog and The Scorpion Too.

published: February, 27, 2018 Written by // Matt Levine Categories // Aging, Social Media, Gay Men, Food, Nutrition and Recipes, Health, Living with HIV, Vitamins - Supplements, Media, Opinion Pieces, Matt Levine

Matt Levine: "So as the new year unfolds, I’m taking this look back, less a review, more an emotional detox..."

Mindfulness, The Frog and The Scorpion Too.

Part 1:  The frog   These days my emotional orbit seems to range wider than the Voyager 1 Space probe. True, that’s overly dramatic and quantifiably false, but cosmic exaggeration aside, there does seem to be some distant, vast and dark void between my moods. Last year was tough. Somewhere between a doozy and a mind-fuck, a roller coaster and a road trip with people you hate. But that assessment makes me wince. How can frustration coexist with thirty years of living well with HIV?  Surv

Beyond donor dollars for health care: how Uganda is thinking outside the box

published: February, 27, 2018 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Activism, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Health, Revolving Door, Treatment, Guest Authors

From The Conversation, Henry Zakumumpa reports on how Uganda is closing its funding gap for the scale-up of antiretroviral treatment and service delivery

Beyond donor dollars for health care: how Uganda is thinking outside the box

Over the last 15 years, there’s been a rapid increase in the number of patients receiving HIV treatment in sub-Saharan Africa. This has largely depended on foreign aid, particularly from global aid organisations such as the President’s Emergency Plan for AIDS Relief (PEPFAR) and The Global Fund. Millions of lives have been saved and the quality of life of those living with HIV has been improved dramatically. In recent years there have been persistent reports of a decline in the amou

HIV prevention: It’s time to stop accepting the status quo, PrEP Summit concludes

published: February, 26, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, International AIDS Conference , As Prevention , Conferences, Current Affairs, Treatment Guidelines -including when to start, Health, International , Treatment, Revolving Door, Media, Guest Authors, Opinion Pieces

From AIDSmap, Gus Cairns reports on the PrEP In Europe Summit 2018

HIV prevention: It’s time to stop accepting the status quo, PrEP Summit concludes

The biggest barrier to HIV pre-exposure prophylaxis (PrEP) becoming more available and more widely used is not cost so much as widespread acceptance of the status quo in HIV prevention, the first-ever European PrEP Summit, held in Amsterdam ten days ago, heard. Ignorance – among politicians, among healthcare workers, and among potential users of PrEP – was the main reason Europe lags far behind the USA in PrEP provision, despite there being a possibly more favourable climate in terms of p

Old news

published: February, 23, 2018 Written by // Bob Leahy - Publisher Categories // Social Media, Aging, Gay Men, Health, Living with HIV, Media, Opinion Pieces, Bob Leahy - Publisher

PositiveLite.com publisher Bob Leahy reports from the front lines of the aging experience and says “it’s not all about HIV”

Old news

I’ve had to deal with a few health complications since the start of the year. HIV and aging is becoming all too real. Or is it just aging, period? Have we over-complicated the experience that lies ahead for us by over-focusing on HIV- related issues? I don’t want to make the case that HIV doesn’t complicate the aging experience. There is a large body of evidence to suggest it does and we have been conditioned to treat the two conditions as if intertwined. But they are not always equal p

On-demand PEP to prevent HIV infection

published: February, 23, 2018 Written by // CATIE - HIV and Hep C Info Resource Categories // African, Caribbean and Black, Social Media, As Prevention , Gay Men, Treatment Guidelines -including when to start, Women, Health, CATIE - HIV and Hep C Info Resource, Treatment, Media

“HIV PEP-in-pocket (PIP)" designed to help those “who do not meet criteria for daily or on-demand PrEP" From CATIE, Sean R.Hosein reports.

On-demand PEP to prevent HIV infection

- Post-exposure prophylaxis (PEP) can prevent HIV infection up to 72 hours after exposure - To expedite initiation of PEP, two Toronto clinics prescribed the medication in advance - 13% of “PEP-in-pocket” prescriptions were filled, resulting in zero infections There are several options to reduce a person’s risk of becoming infected with HIV during sex. One option increasingly used in Canada and other high-income countries involves the use of a pill containing two anti-HIV medicines—

Stopping stigma in you will stop stigma against you!

published: February, 22, 2018 Written by // Kimutai Kemboi, Categories // African, Caribbean and Black, Social Media, Activism, Kimutai Kemboi, General Health, Mental Health, Health, International , Living with HIV, Media, Opinion Pieces

From Kenya, Kimutai Kemboi writes on the importance of self-acceptance.

Stopping stigma in you will stop stigma against you!

I have experienced a great change in my life since I accepted my status and decided to move on. Unlike my past, when I used to live without peace and my heart full of guilt and pain. Things drastically changed when I acknowledged that I was HIV-positive and decided to lead a positive life. Now I can smile, make fun and interact with people freely, without fear of victimization nor stigmatisation because the guilt is no longer part of me. I used to fear issues to do with stigma but I came to

<<  1 [23 4 5 6  >>